Get Your Patriot911 Newsletter In Your Email Inbox
The unusual intense coverage of a new study showing benefits of the Pfizer antiviral drug Paxlovid can best be explained by the collusion between the media and the big drug industry. In its 2022 financial guidance, the company reported Paxlovid revenue of $22 billion. True, the new data are impressive in some ways. But some… Read More »Paxlovid Hype About Long COVID
- Newswire articles and reports are produced by another news agency, and the Patriot911News editors believe you'll find it of interest. All content is attributed, belongs to its respective owners, and is used with permission.
- News2023.01.28‘Outnumbered’ co-hosts react with horror to video of Paul Pelosi assault: ‘I saw you look away’
- News2023.01.28Pence discusses ‘very humbling week’ after classified docs were discovered: ‘I take full responsibility’
- News2023.01.28‘There are no facts that can excuse this violation’: Schiff slapped with ethics complaint
- News2023.01.28‘I’m saying it on Fox News. It’s done.’ Ronna McDaniel announces future plans following successful RNC reelection